2010
DOI: 10.1517/14712591003623203
|View full text |Cite
|
Sign up to set email alerts
|

Shingles vaccine

Abstract: The live attenuated zoster vaccine is an effective and well-tolerated method of preventing zoster and the potentially debilitating sequelae and is recommended for immunocompetent patients 60 years of age and older. Ongoing clinical trials are investigating new means of effective prevention.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2010
2010
2021
2021

Publication Types

Select...
3
1

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 41 publications
0
2
0
Order By: Relevance
“…Zostavax is the live attenuated zoster vaccine which is an effective and well-tolerated method of preventing zoster and the potentially debilitating sequelae and is recommended for individuals 60 years of age and older [19,20]. It is a onedose vaccine that boosts varicella-zoster-specific cell mediated immunity.…”
Section: Treatment and Preventionmentioning
confidence: 99%
“…Zostavax is the live attenuated zoster vaccine which is an effective and well-tolerated method of preventing zoster and the potentially debilitating sequelae and is recommended for individuals 60 years of age and older [19,20]. It is a onedose vaccine that boosts varicella-zoster-specific cell mediated immunity.…”
Section: Treatment and Preventionmentioning
confidence: 99%
“…HZ or shingles is characterized by a painful vesicular skin rash (Willison et al, 2010;Yawn and Gilden, 2013). Patients have reported pain ranging from moderate to severe (Bresse et al, 2013), with associated debilitating effects on mood, mobility, sleep and overall quality of life (Lukas et al, 2012).…”
Section: Introduction Of a National Herpes Zoster (Shingles) Immunizamentioning
confidence: 99%